Skip to content

Clinical trials

Multiple Myeloma trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Country / region: Bulgaria Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20101
20111
20123
20131
20141
20173
20191
20202
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen7
Janssen Research & Development, LLC2
Bristol-Myers Squibb1
Celgene1
Celgene Corporation1
Centocor, Inc.1
GlaxoSmithKline1
Karyopharm Therapeutics Inc1
Oncopeptides AB1
TME Pharma AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma17
Recurrence4
Neoplasms2
Anemia1
Blood Protein Disorders1
Bone Diseases1
Bone Marrow Diseases1
Bone Marrow Neoplasms1
Bone Neoplasms1
Fractures, Bone1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.